Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Elucidating Lipid Nanoparticle Formulation Efficacy using Artificial Cells
EF 2022-23
Résumé
Commonly used genetic drugs include messenger RNA (mRNA) for expressing therapeutic proteins and short interfering RNA (siRNA) for inhibiting the synthesis of pathogenic genes; however, challenges in delivering these large negatively charged molecules into cells is challenging. The use of lipid nanoparticles (LNPs) has shown to be an effective method of delivery as seen by the 2020 mRNA COVID-19 vaccines by Pfizer-BioNTech and Moderna.
After LNPs are administered, they are taken up by cells and are transported through the endosomal pathway, where the acidic environment results in the destabilization and fusion with the endosome causing subsequent drug release. However, this process is still elusive, and studies have shown that this endosomal fusion step is the bottleneck of effective drug delivery and efficacy. By evaluating LNPs and their behaviour against representative artificial cells (or model endosomes), we can elucidate formulations that can perform well in animals or patients. This eliminates the complications from other interferences in living systems. This work can create libraries of novel lipid compositions that can generate LNPs with high efficacy.
Quantitative analysis of the LNPs and its interaction with artificial cells can be done using a type of single-particle fluorescent imaging called “CLiC” (Convex Lens-induced Confinement). We can track the drug and LNP using fluorescent labels.
We hope to develop and validate these artificial cells using lipids that are inherently found within the endosome. Reaction rates and drug release kinetics can be measured to give a better understanding of effective drug-delivery systems. Furthermore, we will then validate lead LNP formulation candidates against real cells to establish any possible correlations.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
485889
Name
Zhang Yao
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating Lipid Nanoparticle Formulation Efficacy using Artificial Cells
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Drug Delivery; Fluorescent Imaging; Lipid Nanoparticle; Microscopy; Nucleic Acid
Abstract
Commonly used genetic drugs include messenger RNA (mRNA) for expressing therapeutic proteins and short interfering RNA (siRNA) for inhibiting the synthesis of pathogenic genes; however, challenges in delivering these large negatively charged molecules into cells is challenging. The use of lipid nanoparticles (LNPs) has shown to be an effective method of delivery as seen by the 2020 mRNA COVID-19 vaccines by Pfizer-BioNTech and Moderna.
After LNPs are administered, they are taken up by cells and are transported through the endosomal pathway, where the acidic environment results in the destabilization and fusion with the endosome causing subsequent drug release. However, this process is still elusive, and studies have shown that this endosomal fusion step is the bottleneck of effective drug delivery and efficacy. By evaluating LNPs and their behaviour against representative artificial cells (or model endosomes), we can elucidate formulations that can perform well in animals or patients. This eliminates the complications from other interferences in living systems. This work can create libraries of novel lipid compositions that can generate LNPs with high efficacy.
Quantitative analysis of the LNPs and its interaction with artificial cells can be done using a type of single-particle fluorescent imaging called “CLiC” (Convex Lens-induced Confinement). We can track the drug and LNP using fluorescent labels.
We hope to develop and validate these artificial cells using lipids that are inherently found within the endosome. Reaction rates and drug release kinetics can be measured to give a better understanding of effective drug-delivery systems. Furthermore, we will then validate lead LNP formulation candidates against real cells to establish any possible correlations.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhang, Yao
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~